Press release
Peripheral Neuropathy Market to Surpass USD 7.6 Billion by 2034
Peripheral Neuropathy Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49859
Key Takeaways
• Market Size (2024): USD 4.9 Billion
• Forecast (2034): USD 7.6 Billion
• CAGR (2025-2034): 4.5%
• Primary Growth Drivers: Rising diabetes and cancer cases, innovation in nerve repair therapies, and improved diagnostic imaging for early detection.
• Leading Companies: Pfizer Inc., Eli Lilly and Company, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Biogen Inc., Johnson & Johnson, and Regenacy Pharmaceuticals LLC.
Market Story
Peripheral Neuropathy refers to nerve damage affecting the peripheral nervous system, leading to pain, numbness, and motor dysfunction. It is most commonly caused by diabetes, autoimmune disorders, infections, and exposure to chemotherapy agents.
The demand for effective treatments has grown due to the global surge in diabetic populations and increased cancer survivorship. Modern approaches now integrate nerve regeneration therapies, neuroprotective agents, and AI-driven diagnostics to improve patient outcomes.
Emerging gene therapy and stem cell-based treatments are showing promise for reversing nerve damage, while advanced imaging techniques like MRI neurography are enabling earlier and more precise diagnosis. Pharmacological innovations, including serotonin-norepinephrine reuptake inhibitors (SNRIs), gabapentinoids, and novel sodium channel blockers, are expanding clinical options for neuropathic pain management.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49859/peripheral-neuropathy-market
Market Segmentation
By Type:
• Diabetic Neuropathy
• Chemotherapy-Induced Neuropathy
• Idiopathic Neuropathy
• Alcoholic Neuropathy
• Others
By Treatment Type:
• Pharmacological Therapies (Anticonvulsants, Antidepressants, Opioids, Topical)
• Physical Therapy
• Surgical Treatments
• Regenerative Medicine & Stem Cell Therapy
By End-User:
• Hospitals
• Specialty Clinics
• Research Institutes
• Homecare
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Recent Developments
• 2025: Pfizer expanded trials for its new sodium channel modulator targeting diabetic neuropathic pain.
• 2024: Biogen Inc. collaborated with Regenacy Pharmaceuticals on nerve repair therapy for chemotherapy-induced neuropathy.
• 2024: Eli Lilly launched an extended-release SNRI formulation to improve pain control and patient adherence.
• 2023: Novartis invested in gene therapy research focused on restoring peripheral nerve function in autoimmune neuropathies.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49859
Expert Insight
"Peripheral neuropathy is one of the most challenging chronic conditions to manage," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
"Innovations in regenerative medicine and neuroprotective pharmacology are offering renewed hope for millions of patients worldwide, especially as AI and imaging accelerate early diagnosis."
Regional Outlook
• North America holds the largest market share (>40%) owing to a high diabetic population, well-established healthcare systems, and strong R&D in neurotherapeutics.
• Europe continues to invest in clinical research and advanced diagnostic platforms for early nerve damage detection.
• Asia Pacific is the fastest-growing region (CAGR above 6%) due to a large diabetic base and increasing access to specialized neurology care in India, Japan, and China.
• Latin America & Middle East are emerging markets focusing on low-cost treatment expansion and digital health integration.
Conclusion
The Peripheral Neuropathy Market is witnessing a paradigm shift from symptomatic relief toward disease-modifying and regenerative therapies. As research progresses in gene therapy, stem cell applications, and AI-based diagnostics, the next decade promises major breakthroughs in reversing nerve damage and improving patient quality of life.
This report is also available in the following languages : Japanese (末梢神経障害市場), Korean (말초신경병증 시장), Chinese (周围神经病变市场), French (Marché de la neuropathie périphérique), German (Markt für periphere Neuropathie), and Italian (Mercato della neuropatia periferica), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49859
Our More Reports:
Pheochromocytoma Market
https://exactitudeconsultancy.com/reports/71562/pheochromocytoma-market
Pharmacy Management System Market
https://exactitudeconsultancy.com/reports/49869/pharmacy-management-system-market
Pain Patch Market
https://exactitudeconsultancy.com/reports/49872/pain-patch-market
Antibiotic Resistance Market
https://exactitudeconsultancy.com/reports/49874/antibiotic-resistance-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peripheral Neuropathy Market to Surpass USD 7.6 Billion by 2034 here
News-ID: 4266658 • Views: …
More Releases from Exactitude Consultancy
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72069
Market Summary
The Partial Seizure Market…
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial…
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063
Market Summary
The Prediabetes Market is expanding rapidly as healthcare…
More Releases for Neuropathy
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding
WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to…
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market
Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,…
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market?
The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The…
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market?
The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses…
Combatting Peripheral Neuropathy: Breakthroughs and Beyond
The Business Research Company recently released a comprehensive report on the Global Peripheral Neuropathy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the peripheral neuropathy market…
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810
This latest report researches the industry structure,…
